Elisabetta Tabolacci
Overview
Explore the profile of Elisabetta Tabolacci including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
839
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Modafferi C, Tabolacci E, Grippaudo C, Chiurazzi P
Genes (Basel)
. 2025 Feb;
16(2).
PMID: 40004475
Primary failure of tooth eruption (PFE) is a rare genetic disorder characterized by the failure of teeth to erupt in the absence of obvious physical obstructions, often resulting in a...
2.
Pizzoferrato M, Lazzarino G, Brancato A, Tabolacci E, Clementi M, Tringali G
Antioxidants (Basel)
. 2025 Feb;
14(2).
PMID: 40002367
The retinal pigment epithelium (RPE) is a highly specialised monolayer epithelium subjected to constant oxidative stress, which, in the long term, favours the development of a complex pathological process that...
3.
Villani L, Pezzullo A, Pastorino R, Maio A, Stollagli F, Tirone C, et al.
PLoS One
. 2025 Jan;
20(1):e0317458.
PMID: 39820939
Background: The study of women exposures and child outcomes occurring in the first 1,000 days of life since conception enhances understanding of the relationships between environmental factors, epigenetic changes, and...
4.
Satolli S, Rossi S, Vegezzi E, Pellerin D, Manca M, Barghigiani M, et al.
J Neurol
. 2024 Nov;
271(12):7650-7651.
PMID: 39499281
No abstract available.
5.
Modafferi C, Tabolacci E, Lo Vecchio F, Cassano I, Bertozzi R, Fargnoli A, et al.
Eur J Hum Genet
. 2024 Sep;
32(11):1402-1411.
PMID: 39327493
Primary failure of tooth eruption (PFE) is an autosomal dominant disease with penetrance defect. While the clinical phenotype is relatively well-defined since the 70 s of the last centuries, much...
6.
Satolli S, Rossi S, Vegezzi E, Pellerin D, Manca M, Barghigiani M, et al.
J Neurol
. 2024 Jun;
271(8):5478-5488.
PMID: 38886208
Background: Autosomal-dominant spinocerebellar ataxia (ADCA) due to intronic GAA repeat expansion in FGF14 (SCA27B) is a recent, relatively common form of late-onset ataxia. Objective: Here, we aimed to: (1) investigate...
7.
Bianchetti G, Bottoni P, Tringali G, Maulucci G, Tabolacci E, Clementi M
Curr Res Pharmacol Drug Discov
. 2024 Jun;
6:100186.
PMID: 38846010
Polyphenols are a class of natural compounds that act as antioxidants, neutralising harmful free radicals that would damage cells and increase the risk of diseases such as cancer, diabetes and...
8.
Grandi M, Galber C, Gatto C, Nobile V, Pucci C, Schaldemose Nielsen I, et al.
Int J Mol Sci
. 2024 Mar;
25(6).
PMID: 38542395
Mitochondria are involved in multiple aspects of neurodevelopmental processes and play a major role in the pathogenetic mechanisms leading to neuro-degenerative diseases. Fragile-X-related disorders (FXDs) are genetic conditions that occur...
9.
Dello Russo C, Di Franco V, Tabolacci E, Cappoli N, Navarra P, Sollazzi L, et al.
Pain
. 2023 Dec;
165(5):972-982.
PMID: 38047761
Recent literature suggests that the withdrawal of remifentanil (RF) infusion can be associated with hyperalgesia in clinical and nonclinical settings. We performed a systematic review and a meta-analysis of randomized...
10.
Dello Russo C, Cappoli N, Tabolacci E, Sollazzi L, Navarra P, Aceto P
EXCLI J
. 2023 May;
22:295-309.
PMID: 37220493
Remifentanil is a potent ultra-short acting μ-opioid analgesic drug, frequently used in anaesthesia due to its favorable pharmacodynamic and pharmacokinetic profile. It may be associated with the occurrence of hyperalgesia....